CMTM6 mediates cisplatin resistance in OSCC by regulating AKT/c-MYC driven ribosome biogenesis
P. Mohapatra, S. Mohanty, S. A. Ansari, O. Shriwas, A. Ghosh, R. Rath, S. K. Das Majumdar, R. K. Swain, S. K. Raghav, R. Dash
This study identifies CMTM6 as a regulator of ribosome biogenesis in cisplatin-resistant OSCC, showing that targeting this pathway can restore chemosensitivity.
bioRxiv · Apr 8, 2022 · PreprintCancer Biology